India  

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Video Credit: ANI - Duration: 02:01s - Published
Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.

A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management.

It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark.

India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year.

India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now.

This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

NHS was within 'six or seven hours' of running out of PPE, says Hancock

Some hospitals in England were within "six or seven hours" of running out of personal protective equipment in the early stages of the COVID pandemic, a former..
Sky News
Eva Longoria Reveals She and Her Family Have Moved Out of the United States | THR News Video [Video]

Eva Longoria Reveals She and Her Family Have Moved Out of the United States | THR News Video

Eva Longoria has revealed that she and her family have moved out of the United States. In a new interview with publication Marie Claire, Longoria said of the U.S., "I had my whole adult life here. But even before [the pandemic], it was changing. The vibe was different. And then COVID happened, and it pushed it over the edge. Whether it's the homelessness or the taxes, not that I want to s*** on California — it just feels like this chapter in my life is done now."

Credit: The Hollywood Reporter    Duration: 01:15Published

Karnataka cabinet OKs SIT probe into ‘BJP-era Covid scam’

The Karnataka government has formed a special investigation team (SIT) to probe alleged financial irregularities during the previous BJP government's handling of..
IndiaTimes

Dominica to bestow its highest civilian award upon PM Modi

Prime Minister Narendra Modi is set to receive the Dominica Award of Honour, Dominica's highest civilian award. The award recognizes PM Modi's contributions to..
IndiaTimes

Related videos from verified sources

What is Virafin? How does the Zydus Cadila drug work? | Oneindia News [Video]

What is Virafin? How does the Zydus Cadila drug work? | Oneindia News

Zydus Cadila's Virafin has been approved for emergency use to treat moderate Covid-19 patients by the drug controller general of india. How does Virafin work? #Virafin #ZydusCadila #CovidDrug

Credit: Oneindia     Duration: 01:24Published
Covid-19: Centre to fast-track emergency approval for vaccines| Oneindia News [Video]

Covid-19: Centre to fast-track emergency approval for vaccines| Oneindia News

The Centre has decided to fast-track emergency approval for COVID-19 vaccines uses in western nations and Japan after the world's biggest surge in cases in the country this month. In view of the rising..

Credit: Oneindia     Duration: 02:13Published
Vaccinations for 12 to 15-year-olds could be available in weeks [Video]

Vaccinations for 12 to 15-year-olds could be available in weeks

Local medical experts believe now that Pfizer has applied for Emergency Use Authorization for their COVID vaccine for those 12-15, that age group could be eligible for a vaccine by the end of the..

Credit: KMTV Action 3 News     Duration: 03:08Published